ESH MM 2018 | Genomics shed light on targeted treatment for myeloma
Nikhil Munshi, MD, from the Dana-Farber Cancer Institute, Boston, MA, reveals how genomics can be used to inform clinical practice for targeted multiple myeloma (MM) treatment at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France. Dr Munshi outlines what genomics can reveal about clonal heterogeneity, as well as how genomics informs research and clinical practice for smoldering myeloma. Overall, current and new sequencing techniques provide deeper understanding of MM biology.
Get great new content delivered to your inboxSign up